Myrexis Competitors and Similar CompaniesClear all

Myrexis's competitors and similar companies include Genocea Biosciences and Oncopeptides.
Myrexis
Myrexis
Myrexis (formerly known as Myriad Pharmaceuticals) is a molecular biopharmaceutical company.
Genocea Biosciences
Genocea Biosciences
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
Oncopeptides
Oncopeptides
Oncopeptides is a clinical development pharmaceutical company.
Founding Date
Founding Date
1999
Founding Date
2006
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Locations
Cambridge, US HQ
Locations
Stockholm, SE HQ
Stockholm, SE
Los Altos, US
Mountain View, US
Waltham, US
Employees
Employees
N/A
Employees
593% decrease
Employees
80
Valuation ($)
Valuation ($)
4.1 m
Valuation ($)
5.7 k
Valuation ($)
42.4 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1.6m (FY, 2021)
Revenue (est.)
kr71.1m (FY, 2025)
Net income
Net income
N/A
Net income
($33.2m) (FY, 2021)
Net income
(kr249.6m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Genocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease

Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.

View company
Oncopeptides
HQ
Stockholm, SE
Employees
80

Oncopeptides is a clinical development pharmaceutical company.

View company